PharmaShots | Incisive News in 3 Shots

Subscribe Now

Exclusive Agreement

Nora Signs an Exclusive Agreement Biopharmaceutical Partner to Launch a Biosimilar in Canada

Nora Signs an Exclusive Agreement Biopharmaceutical Partner to Launch a Biosimilar in Canada

August 24, 2021

Merck Signs an Exclusive Agreement with Dewpoint Therapeutics to Develop Curative Treatment for HIV

Merck Signs an Exclusive Agreement with Dewpoint Therapeutics to Develop Curative Treatment for HIV

July 14, 2020

Nestle Health Science Signs a Worldwide Exclusive Agreement with VALBIOTIS to Develop and Commercialize TOTUM-63 for Reducing the Risk of T2D

Nestle Health Science Signs a Worldwide Exclusive Agreement with VALBIOTIS to Develop and Commercialize TOTUM-63 for Reducing the...

February 6, 2020

Sanofi Signs an Exclusive Agreement with Roche for OTC Rights of Tamiflu (oseltamivir phosphate) in the US

Sanofi Signs an Exclusive Agreement with Roche for OTC Rights of Tamiflu (oseltamivir phosphate) in the US

July 23, 2019

Celyad Signs an Exclusive License Agreement with Horizon Discovery for its shRNA Technology

Celyad Signs an Exclusive License Agreement with Horizon Discovery for its shRNA Technology

October 4, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us